The medicine Levonelle is used for emergency intervention in the therapeutic domain of emergency contraception.

The primary use of Levonelle is focused on addressing the acute risk of unintended pregnancy, making it relevant in two main clinical scenarios: in situations involving a high potential for conception and after an instance of contraceptive failure, such as a condom break or missed routine pill doses. The medicine is generally applied across domains where additional symptomatic support is needed by addressing this potential for an unwanted pregnancy.

Addressing the Acute Risk of Unintended Pregnancy

Levonelle is commonly used across conditions presenting with acute episodes that arise in contexts involving episodic or fluctuating manifestations. This intervention provides support that contributes to easing the overall symptom load, which helps maintain a sense of stability when symptoms are more noticeable.

“This measure is commonly used across conditions presenting with acute episodes that require short-term supportive management.”

Supportive Measure Following Contraceptive Mishap

This medicine is considered relevant in contexts marked by increased discomfort or tension following a contraceptive accident. It is generally applied in scenarios where short-term symptomatic assistance is needed to manage symptoms that create noticeable physiological strain from the lapse in protection. The key benefit is offering a supportive measure for acute situations that helps maintain a sense of stability following the disruption of a planned reproductive health strategy.

Quick Fact: Relief for Acute Risk
Provides supportive relief when symptoms that create noticeable physiological strain interfere with routine activities.

Regulatory References

1. NIH MedlinePlus Drug Information

Levonelle is officially indicated only for women of childbearing potential, including postpubertal adolescents. Use is not indicated for pre-menarcheal girls or postmenopausal women, as stated in regulatory labeling.

Contraindications (Must Not Use)

The medicine is contraindicated in two primary groups:

• Individuals with a known or suspected existing pregnancy (it is ineffective once pregnancy is established).
• Individuals with known hypersensitivity or allergy to the active substance, Levonorgestrel, or any of the product's excipients.

Conditional Use and Restrictions

Certain medical conditions or histories require careful consideration, and the use of Levonelle may be not advised or restricted by a healthcare professional:

Population/Condition	Regulatory Stance
Severe Hepatic Impairment	Use is not advised (severe liver problems).
Malabsorption Disorders	Not advised in conditions like Crohn's disease that inhibit drug absorption.
Ectopic Pregnancy History	Use requires caution due to an increased risk of a new ectopic pregnancy.
Lactation	Levonorgestrel passes into breast milk in small amounts; Progestin-only contraceptives are generally considered the hormonal contraceptives of choice during breastfeeding.

Eligibility is defined by regulatory documents based on reproductive status and specific health risks, serving as the official guide for its safe and proper use.

The effectiveness of Levonelle (levonorgestrel) as an emergency contraceptive may be significantly reduced when taken with certain other medicines and herbal products.

Impact on Levonelle Efficacy

This reduction in efficacy is primarily due to liver enzyme inducers, which speed up the breakdown and removal of levonorgestrel from the body, lowering its plasma concentration. The main enzymes involved are CYP3A4.

Medicines and products that may reduce Levonelle's effectiveness include:

• Medicines for Epilepsy: Such as barbiturates (e.g., primidone), phenytoin, and carbamazepine.
• Medicines for Tuberculosis: Such as rifampicin and rifabutin.
• Medicines for HIV: Including ritonavir and efavirenz.
• Medicines for Fungal Infections: Including griseofulvin.
• Herbal Products: Containing St John's wort (Hypericum perforatum).

Management of Interactions

For women who have used any of these enzyme-inducing medicines within the last four weeks, the official recommendation is to preferably use a non-hormonal emergency contraceptive, such as a copper intrauterine device (Cu-IUD). If a Cu-IUD is not suitable, an alternative management option is to take a double dose (3000 micrograms) of Levonelle to compensate for the lower plasma levels.

Other Interactions

Levonorgestrel may also increase the risk of toxicity of medicines containing ciclosporin by inhibiting its metabolism.

Levonelle contains levonorgestrel, a synthetic progestogen that acts primarily as a progesterone receptor agonist. Following oral administration, levonorgestrel achieves systemic circulation and targets the hypothalamic-pituitary-ovarian (HPO) axis.

Within the hypothalamus, it binds to and modulates the activity of progesterone receptors, initiating a negative feedback cascade. This interaction slows the pulsatile release of gonadotropin-releasing hormone (GnRH). The reduced GnRH signaling consequently suppresses the anterior pituitary gland's secretion of luteinizing hormone (LH), thereby preventing the normal mid-cycle LH surge. The system-level physiological consequence of blunting the LH surge is the inhibition or delay of follicular rupture, which constitutes the process of ovulation. This mechanism is most pronounced when the compound is administered prior to the initiation of the pre-ovulatory LH rise. Levonorgestrel also induces an increase in the viscosity of cervical mucus, creating a physical barrier that restricts the motility and transmigration of sperm into the upper reproductive tract.

How Levonelle is Used

Levonelle (Levonorgestrel) is a solid oral dosage form administered as a single, fixed dose for emergency contraceptive use. This medicine is strictly intended as an acute intervention and is not suitable for routine or regular use as an ongoing method of birth control.

---

Official Administration Protocol

The entire dose of Levonelle must be taken as a single administration. The timing of administration is critical for its labeled use. It must be taken as soon as possible following unprotected sexual intercourse or contraceptive failure, ideally within 12 hours, but no later than 72 hours (three days). The tablet can be consumed with or without food, along with water.

---

Dosage and Procedural Constraints

The standard adult dose, which is also approved for post-menarcheal adolescents, is a single tablet containing 1.5 mg of Levonorgestrel. This fixed regimen defines the official course of treatment.

Procedural Constraint	Official Guideline
Timing	Must be taken within 72 hours of the incident.
Dose	Single 1.5 mg tablet.
Vomiting Contingency	If vomiting occurs within three hours of taking the tablet, a second 1.5 mg tablet should be taken immediately.

In specific, high-level clinical contexts—such as concurrent use of certain enzyme-inducing medicines—some prescribing guidelines may recommend a higher, 3.0 mg dose. However, the standard regulated dose remains 1.5 mg for most users.

Levonelle (levonorgestrel, 1.5 mg) is an oral emergency contraceptive pill (ECP). Clinical research focuses on its effectiveness, timing, and potential limitations.

Mechanism of Action

Studies consistently suggest that the primary way levonorgestrel works is by preventing or delaying ovulation (the release of an egg from the ovary). It exerts this effect mainly before the natural surge of luteinizing hormone (LH) that triggers ovulation begins. The medication is not considered effective once ovulation has already occurred. Current evidence generally does not support a significant effect on the endometrium or on implantation after fertilization.

---

Efficacy and Timing

The effectiveness of levonorgestrel is highly dependent on the time elapsed since unprotected sexual intercourse. Overall pregnancy prevention rates reported in clinical trials and meta-analyses range from approximately 52% to 94% of expected pregnancies, depending on the interval before administration. Efficacy is highest when the dose is taken within the first 24 hours and declines significantly if administration is delayed, particularly beyond 72 hours (three days).

Timing after Unprotected Sex	Efficacy Trend (Approximate)
Within 24 hours	Highest efficacy
25-48 hours	Moderate efficacy
49-72 hours	Decreased efficacy

---

Factors Affecting Efficacy

Recent research has explored factors that may influence effectiveness:

• Body Weight/BMI: Some studies have suggested a potential reduction in effectiveness among individuals with a higher body mass index (BMI) or body weight, particularly above 75–80 kg. However, this is challenged by some recent reviews, and current public health guidelines do not universally restrict its use based on weight alone.
• Drug Interactions: Medications that induce liver enzymes (e.g., certain anti-epileptic drugs) can reduce levonorgestrel's concentration in the body, potentially lowering its effectiveness. Individuals taking such medications may require a higher dose or alternative emergency contraception methods.

Common questions about Levonelle (FAQ)

Q: Is Levonelle the same as Plan B?

A: Levonelle is a brand name used in the UK and Europe for the emergency contraceptive containing 1.5 mg of the active ingredient levonorgestrel. The brand Plan B is another widely recognized product containing the same active ingredient. These products contain the same medicine used for emergency pregnancy prevention.

Q: Does Levonelle interact with common pain relievers like ibuprofen?

A: Official documents listing drug interactions for levonorgestrel do not cite common pain relievers, such as ibuprofen or paracetamol, as agents that interfere with the effectiveness of the emergency contraceptive. This information suggests that these over-the-counter pain medications are generally not known to reduce how well levonorgestrel works.

Q: Are there any long-term effects associated with taking Levonelle?

A: The most frequently reported effects in regulatory documents are described as generally transient, meaning they are temporary and short-lived, typically experienced shortly after the single dose. Official product labeling for the single-dose emergency use of levonorgestrel does not define specific long-term adverse events.

Q: Can herbal supplements interfere with Levonelle?

A: The herbal product St John's wort (Hypericum perforatum) is specifically described in official documents as a known enzyme inducer that may significantly reduce the effectiveness of levonorgestrel. If a person is taking this or other herbal products, awareness of potential interactions is recommended, as this is consistent with official guidance.

Q: What should a person expect concerning their next period after taking Levonelle?

A: Official documents state that levonorgestrel may alter the next expected menstrual period, which may be earlier or later than usual. If menstruation is delayed beyond one week, official sources indicate that checking for pregnancy is considered appropriate to assess the situation.

Q: Is Levonelle an abortion pill?

A: Levonelle is not effective in terminating an existing pregnancy. Its primary mechanism of action is described in official documents as preventing or delaying ovulation (the release of an egg), which occurs before fertilization and implantation can take place.

Q: What types of medications are known to affect how Levonelle works?

A: Medicines known to affect levonorgestrel efficacy include those that increase liver enzyme activity. This covers certain medicines for conditions like epilepsy, tuberculosis (TB), HIV, and fungal infections. Additionally, levonorgestrel may also increase the levels of medicines containing ciclosporin.

Q: Is there a body weight limit mentioned for taking Levonelle?

A: Current official product labeling does not impose a body weight or body mass index (BMI) restriction for the use of Levonelle. However, some clinical studies noted in regulatory research have suggested a potential reduction in effectiveness in individuals with a higher BMI.

Q: Does Levonelle work if taken several days after?

A: Official regulatory documents indicate that levonorgestrel is approved for use only within 72 hours (three days) of the incident. Taking it outside of this specific time window is not part of the licensed use, and efficacy beyond 72 hours has not been established in the official product information.

Q: Can I take Levonelle if I have a history of blood clots?

A: Official labeling notes that thromboembolic events, which are serious blood clots, have been reported rarely after use. While a history of blood clots is often an important consideration for regular hormonal contraceptives, it is a point of caution to be considered for this emergency, single-dose use.

Q: What is the difference between Levonelle and ellaOne (ulipristal acetate)?

A: Levonelle contains the progestogen levonorgestrel, while ellaOne contains a different active substance called ulipristal acetate. These differences in chemical composition mean the products have different regulatory time windows and slightly different mechanisms of action for emergency contraception.

Q: Are there any official guidelines regarding repeated use of Levonelle?

A: Official regulatory warnings state clearly that Levonelle is not suitable for routine or regular use as an ongoing method of birth control. If the medicine is used more than once in the same cycle, it is noted as being more likely to cause menstrual cycle disturbance.

Q: Does Levonelle stop pregnancy from continuing if a person is already pregnant?

A: Levonelle is ineffective once a pregnancy is established and will not terminate an existing pregnancy. This medicine is primarily intended to intervene before conception can occur, typically by delaying or preventing ovulation.

Q: How does alcohol affect the use of Levonelle?

A: Official product labeling does not mention alcohol as an agent that interferes with the efficacy of levonorgestrel. However, alcohol consumption may worsen common temporary side effects of the tablet, such as nausea or dizziness.

Q: What does it mean if Levonelle 'fails'?

A: Failure means that a pregnancy still occurs despite having taken the emergency contraceptive. Official documents report varying rates of efficacy and advise that the possibility of an ectopic pregnancy, where the fertilized egg implants outside the womb, should be considered in cases of treatment failure.

Q: Can Levonelle affect the effectiveness of regular birth control pills?

A: Levonorgestrel emergency contraception itself does not typically affect the long-term effectiveness of regular hormonal contraceptives. However, official guidance indicates that a person should resume or start a reliable barrier or hormonal method to ensure ongoing pregnancy prevention.

Q: Does taking Levonelle make a person infertile later on?

A: Regulatory documents state that a rapid return of fertility is likely following the single-dose treatment. Official information indicates that Levonelle is not linked to causing long-term infertility.

Q: Are there specific food items that interact with Levonelle?

A: Official labeling typically advises that the tablet can be taken with or without food. Some information advises caution regarding grapefruit juice, as it is known to affect the metabolism (breakdown) of certain medicines in the body.

Q: What official bodies regulate the use of Levonelle?

A: The regulation of Levonelle is overseen by national or regional governmental drug authorities. Examples include the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, the European Medicines Agency (EMA), and the Food and Drug Administration (FDA) in the US for the generic drug.

Q: Are there official warnings about combining Levonelle with certain antibiotics?

A: Official warnings specifically cite rifampicin and rifabutin, which are antibiotics used to treat tuberculosis (TB), as medicines that can reduce the effectiveness of levonorgestrel. Most common, non-enzyme-inducing antibiotics are generally not specified in the warnings.

Q: Can I use Levonelle if I have diabetes?

A: Official prescribing information does not list diabetes as a contraindication (a condition that strictly prohibits use) for the single-dose emergency contraceptive. However, conditions like diabetes are generally considered as factors for caution with hormonal medicines.

Q: Is Levonelle available in different doses?

A: The standard regulated dose is a single 1.5 mg tablet. Official prescribing guidelines indicate that a higher dose may be considered for patients taking medicines known to reduce its efficacy.

Q: What are the official definitions of 'emergency contraception'?

A: Emergency contraception is officially defined in regulatory documents as a backup or failsafe measure. Its purpose is to prevent pregnancy following unprotected sexual intercourse or when a regular contraceptive method has failed.

Q: Does Levonelle affect the results of home pregnancy tests?

A: Levonorgestrel is a synthetic progestogen and is not the pregnancy hormone (hCG) that home tests detect. Official documents do not indicate that levonorgestrel interferes with the chemical results of a home pregnancy test.

Q: Is it true that Levonelle is less effective the closer it is to ovulation?

A: Official documents describe that levonorgestrel’s mechanism of preventing ovulation is most effective when taken before the start of the pre-ovulatory hormone surge. The medicine is not considered effective once ovulation has already occurred.

Q: Is Levonelle considered a high-risk medication by regulators?

A: Levonelle is classified as an acute intervention drug for emergency use. The official prescribing information lists only existing pregnancy and hypersensitivity (allergy) as contraindications, suggesting a specific 'high-risk' label is not universally applied by regulatory bodies.

Q: Is Levonelle known to cause significant weight gain or loss?

A: Weight gain or loss are not listed among the commonly reported side effects in the official safety profile for the single-dose emergency contraceptive. The side effects listed are typically common and transient (temporary).

Levonelle tablets must be stored according to officially documented conditions to maintain product stability and integrity. The following requirements are defined by regulatory labeling:

Storage Requirements

• Temperature Control: Store the medicine at room temperature, typically between 20 C to 25 C (68 F to 77 F), with storage below 25 C often specified. The product must be kept from freezing and away from excessive heat.
• Protection: The tablets must be stored in the original package in order to protect from light and moisture.
• Child Safety: It is strictly required that the medicine be kept out of the sight and reach of children.

Disposal Instructions

Any unused or expired Levonelle must be disposed of according to local requirements. Regulatory documents explicitly state the medicine must not be disposed of via wastewater or household waste. Patients should ask their pharmacist for guidance on proper pharmaceutical waste disposal.